Home > Healthcare > Medical Devices > Diagnostic Devices > us pet ct scanner market
Get a free sample of U.S. PET-CT Scanner Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of U.S. PET-CT Scanner Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
U.S. PET-CT scanner market size was valued at around USD 864 million in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032. PET-CT scanner is a medical imaging device that combines positron emission tomography (PET) and computed tomography (CT) technologies into a single machine.
PET scans detect the metabolic activity of cells by using radioactive tracers, while CT scans provide detailed structural images. This simultaneous acquisition of functional and anatomical information helps in enhancing the diagnostic capabilities, particularly in oncology, cardiology, and neurology.
Rapid innovations, marked by frequent product launches aimed at enhancing imaging quality and reducing scan times, are propelling the growth of the U.S. PET-CT scanner market. Noteworthy advancements, such as the introduction of digital PET scanners boasting superior sensitivity and resolution, are set to significantly bolster this market's expansion. Furthermore, the U.S. healthcare system's focus on personalized medicine has spurred a heightened reliance on PET scans, especially for precise tumor localization and monitoring treatment responses.
Concurrently, cancer stands as the second leading cause of death in the U.S. The American Cancer Society forecasts around 2,001,140 new cancer cases and over 611,720 cancer-related deaths in 2024. This rising incidence underscores the urgency for enhanced diagnostic tools, propelling the demand and growth of the PET-CT scanner market.
Additionally, collaborations between technology companies and healthcare providers are driving research into new radiotracers. These radiotracers can target specific diseases more effectively, thus expanding the clinical applications of PET technology. For instance, in February 2024, IONETIX, a leader in cyclotron technology and isotope production, announced a partnership with Provision Diagnostic Imaging in Knoxville. The collaboration centered on the use of IONETIX's on-site production of N-13 Ammonia for cardiac PET/CT imaging. Provision Diagnostic Imaging, known for introducing advanced diagnostic technologies to East Tennessee, integrated this innovation to enhance its cardiac diagnostic services.
The digital PET-CT scanner segment recorded USD 511.8 million in 2023 and is expected to grow significantly due to superior resolution, increased sensitivity, and long-term stability offered by advanced digital photon-counting technology.
The U.S. PET-CT scanner industry was valued at approximately USD 864 million in 2023 and is estimated to grow at a 5.9% CAGR from 2024 to 2032, driven by advancements in medical imaging technology.
Northeast U.S. PET-CT scanner industry generated USD 177.1 million in 2023 and is projected to witness substantial growth, supported by a robust healthcare infrastructure with numerous academic medical centers and hospitals.
Key players in the market include Bruker Corporation, Canon, GE HealthCare, Koninklijke Philips, Mediso, MinFound Medical Systems, MR Solutions, and Neusoft Medical Systems.